InsidersTradesSigma
Follow the Intergrum AB share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Intergrum AB has published 1 insider filings. Market capitalisation: €215.5m. The latest transaction was filed on 9 December 2025 (Purchase). Among the most active insiders: Martin Hillsten. The full history is openly available.
1
Insider Decl.
n/a
Thresholds
€27,491
1 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
Fundamental score
Ranked 26,127 of 28,803 companies
21.1
score / 100
Value9
Quality33
FCF yld-27%
Earn yld-22%
EV/EBITDA·
ROE-27%
Gross mgn69%
Net mgn-51%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 December 2025
Declarations1 total
29,002 shares@ €0.94790.013% mcap100.0% of flowAktieISIN SE0009807266FI:A003U537-1
1 of 1 declaration
About Intergrum AB
Intergrum AB is a healthcare and pharmaceutical company listed on the Stockholm Stock Exchange. It focuses on developing innovative solutions to enhance healthcare.